Table 1.
Characteristics of the study sample.
| Study sample (n = 403) | |
|---|---|
| Age, median (IQR), years | 71 (60–78) |
| Male, n% | 266 (66.0) |
| Symptoms upon ED visit, n% | |
| Fever | 249 (61.8) |
| Cough | 287 (71.2) |
| Dyspnoea | 278 (69.0) |
| General malaise | 187 (46.4) |
| Headache | 52 (12.9) |
| Thoracic pain | 61 (15.1) |
| Nausea | 92 (22.8) |
| Diarrhoea | 90 (22.3) |
| No respiratory symptoms | 55 (13.6) |
| PCR positive, n% | 323 (80.1) |
| Chest CT scan positive, n% | 325 (80.6) |
| Outcomes | |
| Admission to hospital, n% | 307 (76.2) |
| Length of hospital stay, median (IQR), days | 6 (3-12) |
| Treatment restrictions, n% | 142 (35.2) |
| Mortality within 14 days, n% | 77 (19.1) |
| Mortality within 30 days, n% | 95 (23.6) |
| MCU admission, n% | 48 (11.9) |
| ICU admission, n% | 66 (16.4) |
| Composite endpoint (mortality and/or admission to MCU/ICU), n% | 152 (37.7) |
CT: computed tomography; ED: emergency department; ICU: intensive care unit; IQR: interquartile range; MCU: medium care unit; PCR: polymerase chain reaction; SD: standard deviation.